- Home
- THQ vs CRMD Comparison
THQ vs CRMD Comparison
Compare THQ & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THQ | CRMD |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.8M | 626.0M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | THQ | CRMD |
|---|---|---|
| Price | $18.68 | $8.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 108.5K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 7.53% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.59 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $15.14 | $6.13 |
| 52 Week High | $20.39 | $17.43 |
Technical Indicators
Market Signals| Indicator | THQ | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 58.42 | 62.81 |
| Support Level | $18.19 | $6.14 |
| Resistance Level | $18.86 | $8.53 |
| Average True Range (ATR) | 0.28 | 0.38 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 72.59 | 66.56 |
Price Performance
Historical ComparisonAbout THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.